MedPath

Ayurveda Intervention in moderate and severe Covid-19

Phase 2
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J09- Influenza due to certain identified influenza viruses
Registration Number
CTRI/2021/06/034114
Lead Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Typical or atypical clinical presentation of acute onset febrile illness with sore throat and dry cough with or without shortness of breath and a RT_PCR based laboratory confirmation test for COVID-19

2. Patients with either gender, 21 to 70 years age

3. Patients with moderate and severe Covid â?? 19 disease with SPO2 less than 94%

4. Patients willing to participate and sign an informed consent Understands and agrees to comply with planned study procedures.

Exclusion Criteria

1. Patients suffering from COVID-19 Disease with SpO2 level below 80% as judged by a physician

2. Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study

3. Active cancer diagnosis, on palliative treatment or requiring current therapy with antimetabolic agents, immunotherapy or radiotherapy.

4. Patients on complete parenteral nutrition

5. Patients who are likely to worsen or ventilator support due to any reason

6. Pregnancy and lactation

7. Physician decision that involvement in the study is not in the patient´s best interest

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath